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Moore et al have recently published an editorial on ‘Harnessing the power of intelligent 
machines to enhance primary care’.1 Whilst we appreciate the main messages of the 
editorial, we would like to correct the impression given by the authors in relation to one 
of our studies QRISK3.2  As stated in our QRISK3 paper,2 we included seven additional 
parameters in QRISK3 in response to the 2014 update to the NICE guidelines and 
published literature.3-8 These were chronic kidney disease (stages 3, 4, 5); a measure 
of systolic blood pressure variability; migraine; corticosteroids; SLE; atypical 
antipsychotics; severe mental illness. 
 
The paper by Weng et al highlighted only identified two of these,9 and was published the 
year after our paper was submitted to the BMJ.10 It’s inaccurate therefore to attribute 
the development of QRISK3 to machine learning techniques. Also for clarification the 
improvement in accuracy of 3.6% referred to from the paper by Weng et al was not in 
comparison to QRISK2 but to the published equations in the 2013 American ACC/AHA 
guidelines. Their highest c statistic value of 0.764 from the machine-learning algorithms 
was lower than ours for either the current version of QRISK2 (0.879 in women and 0.858 
in men) or the new QRISK3 (0.880 in women and 0.858 in men). 
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